{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:09:42Z","timestamp":1785190182284,"version":"3.55.0"},"reference-count":66,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>Migraine is the second largest cause of years lost to disability globally among all diseases, with a worldwide prevalence over 1 billion. Despite the global burden of migraine, few classes of therapeutics have been specifically developed to combat migraine. After 30 years of translational research, calcitonin gene-related peptide (CGRP) inhibitors have emerged as a promising new tool in the prevention of migraine. Like all new therapeutics; however, we have limited real-world experience and CGRP has several known systemic actions that warrant consideration. This article provides a narrative review of the evidence for CGRP antagonists and summarises the known and potential side effects that should be considered.<\/jats:p>","DOI":"10.1136\/jnnp-2020-324674","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T18:24:20Z","timestamp":1611599060000},"page":"1325-1334","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":45,"title":["Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects"],"prefix":"10.1136","volume":"92","clinical-trial-number":[{"clinical-trial-number":"nct03096834","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03096834","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03777059","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03855137","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04054024","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03941834","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-5507","authenticated-orcid":false,"given":"Jason Charles","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuu-Jiun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bendtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjit","family":"Matharu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8543-7767","authenticated-orcid":false,"given":"Elspeth Jane","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"2022011011051729000_92.12.1325.1","unstructured":"International Headache Society . The International classification of headache disorders 3rd edition, 2019. Available: https:\/\/ichd-3.org\/1-migraine\/1-1-migraine-without-aura\/ [Accessed 12 Aug 2019]."},{"key":"2022011011051729000_92.12.1325.2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1526-4610.2005.4501001.x","article-title":"Migraine: epidemiology, impact, and risk factors for progression","volume":"45 Suppl 1","author":"Lipton","year":"2005","journal-title":"Headache"},{"key":"2022011011051729000_92.12.1325.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32279-7."},{"key":"2022011011051729000_92.12.1325.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30499-X"},{"key":"2022011011051729000_92.12.1325.5","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414547138"},{"key":"2022011011051729000_92.12.1325.6","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00034.2015"},{"key":"2022011011051729000_92.12.1325.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01538-0"},{"key":"2022011011051729000_92.12.1325.8","doi-asserted-by":"crossref","DOI":"10.1111\/j.1526-4610.2007.00776.x","article-title":"Hypothalamic activation in spontaneous migraine attacks","volume":"47","author":"Denuelle","year":"2007","journal-title":"Headache"},{"key":"2022011011051729000_92.12.1325.9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww097"},{"key":"2022011011051729000_92.12.1325.10","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430108"},{"key":"2022011011051729000_92.12.1325.11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00142.x"},{"key":"2022011011051729000_92.12.1325.12","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/head.12656","article-title":"The journey to establish CGRP as a migraine target: a retrospective view","volume":"55","author":"Edvinsson","year":"2015","journal-title":"Headache"},{"key":"2022011011051729000_92.12.1325.13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40259-017-0250-5","article-title":"CGRP monoclonal antibodies for migraine: rationale and progress","volume":"31","author":"Yuan","year":"2017","journal-title":"BioDrugs"},{"key":"2022011011051729000_92.12.1325.14","doi-asserted-by":"publisher","DOI":"10.1038\/304129a0"},{"key":"2022011011051729000_92.12.1325.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2014.11.031"},{"key":"2022011011051729000_92.12.1325.16","doi-asserted-by":"publisher","DOI":"10.1038\/nm0795-658"},{"key":"2022011011051729000_92.12.1325.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01829.x"},{"key":"2022011011051729000_92.12.1325.18","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0439-13.2013"},{"key":"2022011011051729000_92.12.1325.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01278.x"},{"key":"2022011011051729000_92.12.1325.20","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2014.00023","article-title":"Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis","volume":"8","author":"Assas","year":"2014","journal-title":"Front Neurosci"},{"key":"2022011011051729000_92.12.1325.21","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1987.126"},{"key":"2022011011051729000_92.12.1325.22","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410368444"},{"key":"2022011011051729000_92.12.1325.23","doi-asserted-by":"crossref","unstructured":"Russell FA , King R , Smillie SJ , et al . \u201cCalcitonin gene-related peptide: physiology and pathophysiology,\u201d Physiological reviews, vol. 94, no. 4. American Physiological Society, pp. 1099\u20131142, 01-Oct-2014.","DOI":"10.1152\/physrev.00034.2013"},{"key":"2022011011051729000_92.12.1325.24","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(85)90178-0"},{"key":"2022011011051729000_92.12.1325.25","doi-asserted-by":"publisher","DOI":"10.1016\/0167-0115(85)90013-8"},{"key":"2022011011051729000_92.12.1325.26","doi-asserted-by":"publisher","DOI":"10.1038\/313054a0"},{"key":"2022011011051729000_92.12.1325.27","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(92)90036-Y"},{"key":"2022011011051729000_92.12.1325.28","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-020-01102-9","article-title":"Real-Life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy","volume":"21","author":"Ornello","year":"2020","journal-title":"J Headache Pain"},{"key":"2022011011051729000_92.12.1325.29","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/0333102419854082","article-title":"Long-Term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine","volume":"39","author":"Ashina","year":"2019","journal-title":"Cephalalgia"},{"key":"2022011011051729000_92.12.1325.30","unstructured":"Macdonald IAW , Gaigher I , Gaigher R . New drugs for flu, migraines. QuarterWatch, Inst safe Med Pract 2019."},{"key":"2022011011051729000_92.12.1325.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.06.021"},{"key":"2022011011051729000_92.12.1325.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5150"},{"key":"2022011011051729000_92.12.1325.33","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90270-P"},{"key":"2022011011051729000_92.12.1325.34","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/head.13591","article-title":"CGRP and brain functioning: cautions for migraine treatment","volume":"59","author":"Borkum","year":"2019","journal-title":"Headache"},{"key":"2022011011051729000_92.12.1325.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047308","article-title":"Expression of calcitonin gene-related peptide in efferent vestibular system and vestibular nucleus in rats with motion sickness","volume":"7","author":"Xiaocheng","year":"2012","journal-title":"PLoS One"},{"key":"2022011011051729000_92.12.1325.36","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3336-13.2014"},{"key":"2022011011051729000_92.12.1325.37","doi-asserted-by":"publisher","DOI":"10.1159\/000064445"},{"key":"2022011011051729000_92.12.1325.38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0143-4179(93)90051-B","article-title":"Studies on the mechanism of the contractile action of rat calcitonin gene-related peptide and of capsaicin on the guinea-pig ileum: effect of hCGRP (8-37) and CGRP tachyphylaxis","volume":"25","author":"Bartho","year":"1993","journal-title":"Neuropeptides"},{"key":"2022011011051729000_92.12.1325.39","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90645-X"},{"key":"2022011011051729000_92.12.1325.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2010.12.002"},{"key":"2022011011051729000_92.12.1325.41","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02517"},{"key":"2022011011051729000_92.12.1325.42","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01167","article-title":"The regulation of pulmonary vascular tone by neuropeptides and the implications for pulmonary hypertension","volume":"9","author":"Lo","year":"2018","journal-title":"Front Physiol"},{"key":"2022011011051729000_92.12.1325.43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.tips.2016.06.002","article-title":"Wiping out CGRP: potential cardiovascular risks","volume":"37","author":"MaassenVanDenBrink","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"2022011011051729000_92.12.1325.44","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.amjcard.2013.06.029","article-title":"Flow in the left anterior descending coronary artery in patients with migraine headache","volume":"112","author":"Aslan","year":"2013","journal-title":"Am J Cardiol"},{"key":"2022011011051729000_92.12.1325.45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/head.13316","article-title":"A randomized, double-blind, placebo-controlled study to evaluate the effect of Erenumab on exercise time during a treadmill test in patients with stable angina","volume":"58","author":"Depre","year":"2018","journal-title":"Headache"},{"key":"2022011011051729000_92.12.1325.46","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.246"},{"key":"2022011011051729000_92.12.1325.47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.regpep.2011.05.014","article-title":"Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion","volume":"171","author":"Liu","year":"2011","journal-title":"Regul Pept"},{"key":"2022011011051729000_92.12.1325.48","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2002.806"},{"key":"2022011011051729000_92.12.1325.49","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.0000000000004391","article-title":"Erenumab (AMG 334) in episodic migraine","volume":"89","author":"Ashina","year":"2017","journal-title":"Neurology"},{"key":"2022011011051729000_92.12.1325.50","doi-asserted-by":"crossref","first-page":"104286","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.07.002","article-title":"Ischemic stroke associated with calcitonin gene-related peptide inhibitor therapy for migraine: a case report","volume":"28","author":"Aradi","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2022011011051729000_92.12.1325.51","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70067-X"},{"key":"2022011011051729000_92.12.1325.52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0168-8227(92)90069-4","article-title":"Effects of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide (CGRP) on glucose metabolism in the rat","volume":"15","author":"Morishita","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"2022011011051729000_92.12.1325.53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00006676-199803000-00014","article-title":"Isolation and molecular characterization of porcine calcitonin gene-related peptide (CGRP) and its endocrine effects in the porcine pancreas","volume":"16","author":"Rasmussen","year":"1998","journal-title":"Pancreas"},{"key":"2022011011051729000_92.12.1325.54","first-page":"G147","article-title":"Receptor for calcitonin gene-related peptide: binding to exocrine pancreas mediates biological actions","volume":"249","author":"Seifert","year":"1985","journal-title":"Am J Physiol"},{"key":"2022011011051729000_92.12.1325.55","doi-asserted-by":"publisher","DOI":"10.1038\/335632a0"},{"key":"2022011011051729000_92.12.1325.56","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1341441"},{"key":"2022011011051729000_92.12.1325.57","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12020-018-1640-2","article-title":"Serum calcitonin gene-related peptide facilitates adipose tissue lipolysis during exercise via PIPLC\/IP3 pathways","volume":"61","author":"Aveseh","year":"2018","journal-title":"Endocrine"},{"key":"2022011011051729000_92.12.1325.58","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.3892\/mmr.2016.5023","article-title":"\u201cCGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation","volume":"13","author":"He","year":"2016","journal-title":"Mol Med Rep"},{"key":"2022011011051729000_92.12.1325.59","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000168926.44648.ed"},{"key":"2022011011051729000_92.12.1325.60","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.300"},{"key":"2022011011051729000_92.12.1325.61","doi-asserted-by":"crossref","first-page":"B354","DOI":"10.1093\/gerona\/51A.5.B354","article-title":"Sensory peptides as neuromodulators of wound healing in aged rats","volume":"51","author":"Khalil","year":"1996","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2022011011051729000_92.12.1325.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2013.08.001"},{"key":"2022011011051729000_92.12.1325.63","doi-asserted-by":"publisher","DOI":"10.2174\/13892037113149990046"},{"key":"2022011011051729000_92.12.1325.64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430"},{"key":"2022011011051729000_92.12.1325.65","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00463-3"},{"key":"2022011011051729000_92.12.1325.66","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0852-4"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2020-324674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T03:47:14Z","timestamp":1697687234000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2020-324674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":66,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,11,16]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/jnnp-2020-324674"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2020-324674","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]}}}